Reported EBITDA vs. Adjusted EBITDA

Introduction

In every valuation analysis, the EBITDA figure in the denominator of EV/EBITDA is not simply pulled from the income statement. It is adjusted to remove items that distort the company's sustainable earning power: one-time charges, non-recurring revenue, accounting anomalies, and expenses that will not continue under new ownership. The gap between reported EBITDA and adjusted EBITDA can be substantial, sometimes 20-40% of the reported figure, and misunderstanding this gap is one of the fastest ways to misprice a transaction.

Reported EBITDA reflects everything that happened in the past twelve months, including items that are unusual, non-recurring, or unrelated to the company's core ongoing operations. These items distort the multiple calculation and lead to incorrect valuations if left unadjusted.

Consider a company with $100 million in reported EBITDA that includes a $15 million restructuring charge from closing a facility, $5 million in litigation settlement costs, and $3 million in acquisition-related transaction expenses. The adjusted EBITDA, after adding back these non-recurring items, is $123 million. At a 10x EV/EBITDA multiple, the difference between using reported and adjusted EBITDA is $230 million in implied enterprise value: $1.0 billion (reported) vs. $1.23 billion (adjusted). For a live deal, that gap is the difference between a successful transaction and a failed negotiation.

The purpose of adjustments is to answer the question: what will this business earn on a repeatable, ongoing basis under new ownership? This "normalized" earning power is the correct basis for valuation.

Adjusted EBITDA

A non-GAAP (non-standard) financial metric that modifies reported EBITDA by adding back or subtracting items that are deemed non-recurring, non-cash, or unrelated to the company's core ongoing operations. Common add-backs include restructuring charges, litigation costs, acquisition-related expenses, stock-based compensation, and owner-specific expenses. Adjusted EBITDA is the standard metric used in comparable company analysis, precedent transactions, LBO models, and deal pricing negotiations.

Non-Recurring and One-Time Charges

These are expenses that occurred in the past period but are not expected to repeat under normal business operations:

Non-Cash Items

Items that reduce reported earnings but do not represent actual cash outflows:

Owner-Specific Expenses (Private Companies)

In private company M&A, additional adjustments are common for expenses that are specific to the current owner and will not continue under new ownership:

Pro Forma and Run-Rate Adjustments

Pro forma adjustments anticipate changes that have been initiated but not yet fully reflected in the trailing financial results. These are among the most contentious adjustments because they project future benefits rather than correcting historical anomalies:

Pro forma adjustments are legitimate when they are based on documented, verifiable actions that have already been taken (the acquisition has closed, the employees have been terminated, the contract has been signed). They become aggressive when they are based on planned but unexecuted actions (a cost reduction program that has been announced but not yet implemented, a price increase that has been proposed but not yet taken effect).

The line between appropriate and aggressive adjustments is inherently subjective, which is why adjusted EBITDA is one of the most debated metrics in M&A negotiations. The buyer and seller have opposite incentives: the seller wants to maximize adjusted EBITDA (higher valuation), while the buyer wants to minimize it (lower price).

Red Flags for Aggressive Adjustments

Several patterns signal that adjusted EBITDA may be overstated:

Quality of Earnings Report (QoE)

An independent analysis commissioned by the buyer (typically from a Big Four or national accounting firm) that systematically validates or challenges the seller's adjusted EBITDA. The QoE report evaluates each add-back for documentation, recurrence patterns, and reasonableness; identifies adjustments the seller omitted that would reduce EBITDA; and assesses the sustainability of the adjusted figure going forward. The QoE-validated EBITDA often becomes the basis for final deal pricing, and the gap between the seller's presented adjusted EBITDA and the QoE-validated figure directly affects the purchase price. In competitive auction processes, some sellers commission their own "sell-side QoE" to preemptively address buyer concerns and accelerate due diligence.

In most M&A transactions, particularly those involving private equity, the buyer commissions a quality of earnings report from an accounting firm. The QoE report's primary purpose is to validate or challenge the seller's adjusted EBITDA by:

The QoE-validated EBITDA figure often becomes the basis for final deal pricing. The gap between the seller's presented adjusted EBITDA and the QoE-validated figure can be significant, sometimes resulting in a 10-20% downward revision that directly reduces the purchase price.

The EBITDA Reconciliation Table

In sell-side presentations and confidential information memorandums (CIMs), the seller's banker presents a reconciliation table that bridges from reported EBITDA to adjusted EBITDA. This table lists each adjustment, its dollar amount, and a brief description. A well-constructed reconciliation builds buyer confidence by demonstrating that each adjustment is quantified and explainable. A poorly constructed one, with vague descriptions like "other adjustments" or "various one-time items," raises red flags.

The reconciliation table typically follows this format:

Each line item should be supported by documentation that the buyer's QoE team can verify during due diligence.

Over the past decade, the gap between reported and adjusted EBITDA has widened significantly across corporate America. Multiple studies have documented that the average number of adjustments per company has increased, and the magnitude of those adjustments as a percentage of reported EBITDA has grown. Several factors drive this trend:

Low-rate-environment incentives: In the 2020-2021 period, high M&A activity and abundant PE dry powder created strong incentives for sellers to maximize adjusted EBITDA, as every incremental dollar of EBITDA translated to 10-15 dollars of enterprise value at prevailing multiples.

SBC normalization: The inclusion of stock-based compensation as an EBITDA add-back has become widespread in the technology sector, significantly inflating adjusted figures for companies with large equity compensation programs.

COVID-related adjustments: Many companies added back pandemic-related costs (supply chain disruptions, temporary facility closures, remote work transitions) as non-recurring items. While some were genuinely one-time, others reflected structural changes in the business that would persist.

"Community Adjusted EBITDA" and the backlash: WeWork's pre-IPO financials famously presented "community adjusted EBITDA" that excluded marketing, G&A, and other basic operating costs, resulting in a figure that bore little resemblance to actual cash generation. The resulting investor backlash and the company's failed IPO led to increased skepticism of adjusted EBITDA figures across all sectors and more rigorous SEC scrutiny of non-GAAP disclosures.

In Comparable Company Analysis

When building trading comps, the analyst should use adjusted EBITDA for each peer company to ensure apples-to-apples comparison. Most financial data providers (Bloomberg, Capital IQ, FactSet) report consensus EBITDA estimates that approximate adjusted figures, but the analyst should verify that the EBITDA figures are normalized consistently across the peer group.

In Precedent Transaction Analysis

Precedent transaction multiples are almost always calculated using the target's adjusted EBITDA at the time of announcement. The adjustments reflect the seller's presentation of normalized earnings, which the buyer's team validated (or challenged) during due diligence.

In DCF Analysis

The DCF model's explicit period projections should be based on adjusted (normalized) EBITDA, not reported. If the analyst projects from a reported EBITDA base that includes a large one-time charge, the entire projection (and the terminal value that depends on it) will be understated. Starting from a clean, normalized base ensures that the projections reflect sustainable economics.

In LBO Analysis

LBO models use adjusted EBITDA to calculate debt capacity (typically expressed as a multiple of EBITDA), interest coverage ratios, and sponsor returns. Using reported EBITDA that includes non-recurring charges would understate the company's debt capacity and overstate the leverage risk, potentially causing the sponsor to underbid.

The stakes are particularly high in LBO financing because adjusted EBITDA flows directly into the financial covenants of the acquisition debt. If the sponsor borrows at 5.5x adjusted EBITDA and the lender subsequently determines (through its own independent analysis) that the adjustments were aggressive and the true sustainable EBITDA is 15% lower, the effective leverage ratio jumps from 5.5x to nearly 6.5x. This can push the borrower closer to covenant thresholds, increase the risk of technical default, and damage the sponsor's relationship with the lending group. This is why leveraged lending guidelines from the Federal Reserve and OCC require lenders to independently validate EBITDA adjustments, and why transactions with add-backs exceeding 25-30% of reported EBITDA receive heightened regulatory scrutiny.

Notably, leveraged lending guidelines from regulators (including the Federal Reserve and OCC) have pushed back on overly aggressive EBITDA adjustments in the context of leveraged buyout financing. Lenders are required to evaluate leverage ratios based on "properly validated" EBITDA, and regulators have flagged transactions where add-backs exceed 25-30% of reported EBITDA as warranting heightened scrutiny. This regulatory dimension adds a practical ceiling to how aggressively sellers and sponsors can adjust EBITDA in LBO contexts.

In Deal Negotiations

Adjusted EBITDA is typically the single most negotiated financial metric in any M&A transaction. The seller presents their version (maximizing add-backs), the buyer challenges it through the QoE process, and the final deal price often reflects a negotiated EBITDA figure that falls between the two positions.

This negotiation dynamic creates an important role for the investment banker on both sides. The sell-side banker must prepare a credible adjusted EBITDA presentation with well-documented, defensible add-backs that can withstand QoE scrutiny. Presenting aggressively and then retreating under diligence damages credibility and can reduce the final price below what a more conservative initial presentation would have achieved. The buy-side banker must understand which adjustments are legitimate and which should be challenged, and must translate QoE findings into pricing implications for the client.

The adjusted EBITDA figure also flows directly into the key financial covenants in the acquisition financing (maintenance leverage ratios, interest coverage ratios). If the agreed adjusted EBITDA is subsequently found to be overstated, the borrower may breach covenants sooner than expected, creating financial distress risk. This linkage gives lenders a strong incentive to independently validate the adjusted EBITDA before committing financing, creating a third-party check on the seller's and buyer's negotiated figure.